JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (20)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McCammon, A. T.
Right arrow Articles by Nielsen, V. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McCammon, A. T.
Right arrow Articles by Nielsen, V. G.
Related Collections
Right arrow Blood

Anesth Analg 2002;95:844-850
© 2002 International Anesthesia Research Society

CARDIOVASCULAR ANESTHESIA

Hemodilution with Albumin, but Not Hextend®, Results in Hypercoagulability as Assessed by Thrombelastography® in Rabbits: Role of Heparin-Dependent Serpins and Factor VIII Complex

Andrew T. McCammon, MD, Jonathan P. Wright, MD, Mario Figueroa, MD, and Vance G. Nielsen, MD

Department of Anesthesiology, The University of Alabama at Birmingham

Address correspondence and reprint requests to Vance G. Nielsen, MD, Department of Anesthesiology, The University of Alabama at Birmingham, 619 S. 19th St., Birmingham, AL 35249. Address e-mail to vance.nielsen{at}ccc.uab.edu

Isovolemic hemodilution (IVHD) has been advocated as an effective method of reducing the need for transfusion but has been associated with hypercoagulability. We tested the hypothesis that IVHD enhances hemostatic function by decreasing circulating antithrombin activity in rabbits. Furthermore, it was determined whether different replacement solutions would affect hemostasis. Sedated rabbits were randomly assigned to groups that underwent IVHD (40% blood volume removed) with 5% human albumin (n = 10) or a 6% hetastarch solution (Hextend®). Antithrombin and Factor VIII complex (VIII:C) activities were determined, and thrombelastography® was performed with or without platelet inhibition. IVHD resulted in a significant (P < 0.05) decrease in antithrombin (32%–39%) without fluid-specific differences observed. VIII:C did not change in the albumin group, whereas the hetastarch group had a significant (P < 0.05) decrease (43%) in VIII:C that was also significantly (P < 0.05) less than the albumin group. The time to clot initiation was decreased, and the rate of clot formation increased significantly via thrombelastography® in albumin animals. No significant change in clot kinetics was observed in hetastarch animals. In rabbits, the primary determinant of hemostasis after IVHD was the interaction of changes in antithrombin activity and VIII:C. These data serve as a rational basis to determine whether IVHD-mediated hypercoagulability encountered clinically may be attenuated or exacerbated by the choice of colloid administered.

IMPLICATIONS: Isovolemic hemodilution (IVHD) is associated with hypercoagulability. Rabbits hemodiluted with albumin, but not Hextend®, became hypercoagulable secondary to a loss of antithrombin activity with simultaneous maintenance of Factor VIII complex activity (VIII:C). Hextend®-treated animals had proportionate decreases in both antithrombin activity and VIII:C. IVHD-mediated hypercoagulability encountered clinically may be attenuated or exacerbated by the choice of colloid administered.




This article has been cited by other articles:


Home page
 Anesth. Analg.Home page
T. G. Ruttmann, L. F. Montoya-Pelaez, and M. F. M. James
The Coagulation Changes Induced by Rapid In Vivo Crystalloid Infusion Are Attenuated When Magnesium Is Kept at the Upper Limit of Normal
Anesth. Analg., June 1, 2007; 104(6): 1475 - 1480.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
T. T. Niemi, R. T. Suojaranta-Ylinen, S. I. Kukkonen, and A. H. Kuitunen
Gelatin and hydroxyethyl starch, but not albumin, impair hemostasis after cardiac surgery.
Anesth. Analg., April 1, 2006; 102(4): 998 - 1006.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
V. G. Nielsen
Effects of Hydroxyethyl Starch and Calcium on Platelet Activation
Anesth. Analg., May 1, 2005; 100(5): 1538 - 1538.
[Full Text] [PDF]

Home page
 Anesth. Analg.Home page
E. Deusch and S. Kozek-Langenecker
Effects of Hydroxyethyl Starch and Calcium on Platelet Activation
Anesth. Analg., May 1, 2005; 100(5): 1538 - 1539.
[Full Text] [PDF]

Home page
 Anesth. Analg.Home page
V. G. Nielsen, R. T. Lyerly III, and W. Q. Gurley
The Effect of Dilution on Plasma Coagulation Kinetics Determined by Thrombelastography Is Dependent on Antithrombin Activity and Mode of Activation
Anesth. Analg., December 1, 2004; 99(6): 1587 - 1592.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
A. H. Kuitunen, M. J. Hynynen, E. Vahtera, and M. T. Salmenpera
Hydroxyethyl Starch as a Priming Solution for Cardiopulmonary Bypass Impairs Hemostasis After Cardiac Surgery
Anesth. Analg., February 1, 2004; 98(2): 291 - 297.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
T. Ruttmann and V. G. Nielsen
Hemodilution-Induced Hypercoagulability * Response
Anesth. Analg., May 1, 2003; 96(5): 1539 - 1540.
[Full Text] [PDF]


Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins with the assistance of Stanford University Libraries' HighWire Press®. Copyright 2006 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 2002 by the International Anesthesia Research Society.